Escient Pharmaceuticals Stock

Escient Pharmaceuticals is a privately-held biotechnology company focusing on the advancement of G Protein-Coupled Receptor targeted drugs.

Sign up today and learn more about Escient Pharmaceuticals Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Escient Pharmaceuticals Stock

Escient Pharmaceuticals is a provider of bio-technical research and development services intended to focus on the advancement of first-in-class G Protein-Coupled Receptor targeted drugs. Its services focus on offering therapies for neuro-immuno-inflammatory and autoreactive diseases.

Funding History

May 2018$40.0M
September 2020$77.5M
November 2022$120M

Management

Vice President, Finance and Administration

James R. Schmidt

Board Director

Kathleen Sereda Glaub

Chief Executive Officer

Joshua Grass

Board Of Director

Robert Tjian

Board Member

Kevin Raidy

Chief Scientific Officer and Company Cofounder

Marcus F. Boehm

Board Observer

Mira Chaurushiya

Board Member

Charles Zuker

Board Member

Jason P. Hafler

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo